{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:53:53Z","timestamp":1777949633672,"version":"3.51.4"},"reference-count":47,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>The Papanicolaou (Pap) smear, a cornerstone of cervical cancer prevention, has emerged as a compelling, though unconventional, biospecimen for the detection of ovarian cancer (OC). This structured narrative review synthesizes the evolving evidence on the utility of cervicovaginal cytology and molecular analysis of Pap test material for OC detection. While conventional cytology provides a proof of concept, its sensitivity is low, ranging from incidental detection of OC in 0.004% of routine screens to 19.3% in patients with known OC. Specific cytologic findings, however, carry significant predictive value: atypical glandular cells (AGC) confer a two-fold increased OC risk, and psammoma bodies (PB) are strongly associated with serous malignancies. Driven by the sensitivity limitations of morphology, the field has undergone a paradigm shift towards molecular detection. Foundational studies confirmed tumor-derived DNA, including hallmark TP53 mutations, is detectable in Pap samples years before diagnosis, though sensitivity is constrained by low DNA abundance and confounded by background clonal mutations. To overcome this, strategies have expanded to target broader genomic signatures, such as somatic copy number alterations (EVA test: 75% sensitivity, 96% specificity), and multi-gene mutation panels (PapSEEK: 33\u201345% sensitivity). The most promising advances lie in multi-omic approaches, particularly DNA methylation biomarkers, which have demonstrated sensitivities up to 81% with high specificity. Collectively, this evidence argues against repurposing the Pap test as a standalone OC screen but supports its strategic integration into a risk-stratified clinical algorithm. We propose a \u201creflex-to-molecular\u201d model where high-risk cytology (e.g., AGC, PB) automatically triggers advanced molecular testing on the same sample. This model efficiently leverages existing infrastructure to triage high-risk women for definitive diagnostics. Prospective validation of this integrated approach is the essential next step toward transforming this test into a sentinel for malignancies of the upper female reproductive tract.<\/jats:p>","DOI":"10.3390\/medicina62050873","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:06:21Z","timestamp":1777860381000},"page":"873","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Papanicolaou Smear Reimagined: A Narrative Review of Cervicovaginal Cytology and Molecular Biospecimens for Ovarian Cancer Detection"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5134-4466","authenticated-orcid":false,"given":"Andrej","family":"Cokan","sequence":"first","affiliation":[{"name":"Department of Gynaecological and Breast Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia"},{"name":"Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Al Mahdawi","sequence":"additional","affiliation":[{"name":"Department of Gynaecological and Breast Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-7213","authenticated-orcid":false,"given":"Manuela","family":"Ludovisi","sequence":"additional","affiliation":[{"name":"Department of Life Health and Environmental Sciences, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2758-9866","authenticated-orcid":false,"given":"Maja","family":"Paki\u017e","sequence":"additional","affiliation":[{"name":"Department of Gynaecological and Breast Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3543-5920","authenticated-orcid":false,"given":"Jure","family":"Knez","sequence":"additional","affiliation":[{"name":"Department of Gynaecological and Breast Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6959-1836","authenticated-orcid":false,"given":"Andra\u017e","family":"Dovnik","sequence":"additional","affiliation":[{"name":"Department of Gynaecological and Breast Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia"},{"name":"Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e2147343","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from Opportunistic Salpingectomy for Ovarian Cancer Prevention","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"eaap8793","DOI":"10.1126\/scitranslmed.aap8793","article-title":"Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers","volume":"10","author":"Wang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0002-9378(49)90729-2","article-title":"Adenocarcinoma of the ovary diagnosed by vaginal smear","volume":"57","author":"Frech","year":"1949","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1159\/000331294","article-title":"Extrauterine malignancies. Role of Pap smears in diagnosis and management","volume":"43","author":"Gupta","year":"1999","journal-title":"Acta Cytol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000539508","article-title":"Role of Pap Smear Cervical Cytology in the Diagnosis of Extrauterine Malignancies: Largest Study of 104 Cases from Tertiary Care Cancer Centre in India","volume":"68","author":"Tandon","year":"2024","journal-title":"Acta Cytol."},{"key":"ref_9","first-page":"159","article-title":"Cervicovaginal and endometrial cytology in ovarian cancer","volume":"32","author":"Takashina","year":"1988","journal-title":"Acta Cytol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ajcp\/101.3.257","article-title":"The applicability of a keratin 7 monoclonal antibody in routinely Papanicolaou-stained cytologic specimens for the differential diagnosis of carcinomas","volume":"101","author":"Baars","year":"1994","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2009.05.019","article-title":"Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: Results from a large academic womens hospital laboratory employing sensitive screening methods","volume":"114","author":"Zhao","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1067\/mob.2000.106537","article-title":"The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population","volume":"182","author":"Chin","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/JOC.JOC_209_16","article-title":"Histological Follow-Up in Patients with Atypical Glandular Cells on Pap Smears","volume":"34","author":"Boyraz","year":"2017","journal-title":"J. Cytol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4103\/JOC.JOC_54_21","article-title":"Factors Affecting the Histopathological Outcomes of Atypical Glandular Cells on Pap Test","volume":"38","author":"Keles","year":"2021","journal-title":"J. Cytol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000498977","article-title":"Clinicopathological Characteristics of Atypical Glandular Cells Determined by Cervical Cytology in Japan: Survey of Gynecologic Oncology Data from the Obstetrical Gynecological Society of Kinki District, Japan","volume":"63","author":"Toyoda","year":"2019","journal-title":"Acta Cytol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1471-0528.2010.02769.x","article-title":"Risk of gynaecological malignancies in cytologically atypical glandular cells: Follow-up study of a nationwide screening population","volume":"118","author":"Cheng","year":"2011","journal-title":"BJOG"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/gyno.1997.4640","article-title":"Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology","volume":"65","author":"Zweizig","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5468\/OGS.2013.56.2.76","article-title":"Clinicopathological significance of atypical glandular cells on Pap smear","volume":"56","author":"Kim","year":"2013","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5858\/2008-0755-OAR1.1","article-title":"Clinical utility of adjunctive high-risk human papillomavirus DNA testing in women with Papanicolaou test findings of atypical glandular cells","volume":"134","author":"Zhao","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/dc.24871","article-title":"Cytological features of ovarian or tubal high-grade serous carcinoma: A retrospective study of 12 cases with abnormal cervical liquid-based smear","volume":"49","author":"Xu","year":"2021","journal-title":"Diagn. Cytopathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jasc.2020.04.002","article-title":"Psammoma bodies in Papanicolaou tests and associated factors to predict an underlying malignancy: A clinicopathological analysis of 10 cases","volume":"9","author":"Ersoy","year":"2020","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_22","first-page":"693","article-title":"Psammoma bodies in cervicovaginal smears","volume":"97","author":"Zreik","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000325040","article-title":"Peritoneal psammocarcinoma diagnosed by a Papanicolau smear: A case report","volume":"54","author":"Riboni","year":"2010","journal-title":"Acta Cytol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"167ra4","DOI":"10.1126\/scitranslmed.3004952","article-title":"Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers","volume":"5","author":"Kinde","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e207566","DOI":"10.1001\/jamanetworkopen.2020.7566","article-title":"Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis","volume":"3","author":"Paracchini","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15506","DOI":"10.1038\/s41598-019-51697-6","article-title":"Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method","volume":"9","author":"Arildsen","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2019.11.124","article-title":"Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma","volume":"156","author":"Ghezelayagh","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/s41388-024-03089-y","article-title":"TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutations","volume":"43","author":"Ghezelayagh","year":"2024","journal-title":"Oncogene"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"eadi2556","DOI":"10.1126\/scitranslmed.adi2556","article-title":"Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer","volume":"15","author":"Paracchini","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Jiang, X., Li, W., Yang, J., Wang, S., Cao, D., Yu, M., Shen, K., Bai, J., and Gao, Y. (2020). Identification of Somatic Mutations in Papanicolaou Smear DNA and Plasma Circulating Cell-Free DNA for Detection of Endometrial and Epithelial Ovarian Cancers: A Pilot Study. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.582546"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/ijgc-2022-003911","article-title":"Diagnostic accuracy of mutational analysis along the M\u00fcllerian tract to detect ovarian cancer","volume":"32","author":"Pijnenborg","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3892\/ol.2025.14866","article-title":"Analysis of endometrial liquid-based cytology samples to detect somatic mutations and classify ovarian cancer","volume":"29","author":"Kondo","year":"2025","journal-title":"Oncol. Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13148-019-0773-3","article-title":"Ovarian cancer detection by DNA methylation in cervical scrapings","volume":"11","author":"Wu","year":"2019","journal-title":"Clin. Epigenet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40246-025-00763-4","article-title":"Exploring potential methylation markers for ovarian cancer from cervical scraping samples","volume":"19","author":"Lien","year":"2025","journal-title":"Hum. Genom."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e1778","DOI":"10.1002\/ctm2.1778","article-title":"Single-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer","volume":"14","author":"Zhao","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12014-020-09309-3","article-title":"Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics","volume":"18","author":"Boylan","year":"2021","journal-title":"Clin. Proteom."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1631\/jzus.B0920040","article-title":"Liquid-based cytology aids in primary fallopian tube cancer diagnosis","volume":"10","author":"Ren","year":"2009","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1471-0528.2007.01485.x","article-title":"First report of primary fallopian tube cancer diagnosed by liquid-based cytology in an asymptomatic woman","volume":"114","author":"Benjamin","year":"2007","journal-title":"BJOG"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0028-2243(94)90293-3","article-title":"Primary carcinoma of fallopian tube: Experience of six cases","volume":"57","author":"Borghi","year":"1994","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1159\/000325189","article-title":"Primary serous peritoneal carcinoma presenting first on a routine papanicolaou smear: A case report","volume":"54","author":"Wang","year":"2010","journal-title":"Acta Cytol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/gyno.2000.5812","article-title":"Primary peritoneal carcinoma presenting on routine papanicolaou smear","volume":"78","author":"Olsen","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000339007","article-title":"Ovarian serous borderline tumor detected by conventional papanicolaou smear: A case report","volume":"57","author":"Ozen","year":"2013","journal-title":"Acta Cytol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tjog.2013.07.004","article-title":"High grade serous ovarian carcinoma with serous tubal intraepithelial carcinoma in a case presented with atypical glandular cell favor neoplasm cervical cytology and dermatomyositis","volume":"54","author":"Hong","year":"2015","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/dc.21583","article-title":"Cytologic findings in two cases of dermoid cysts with malignant transformation","volume":"39","author":"Mensi","year":"2011","journal-title":"Diagn. Cytopathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000325004","article-title":"Exploiting the residual of cervical thin layer brush samples through cytohistology in cases with invasive carcinoma with application of antibodies","volume":"54","author":"Risse","year":"2010","journal-title":"Acta Cytol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/dc.24153","article-title":"Cytological features of uterine tumors resembling ovarian sex-cord tumors in liquid-based cervical cytology: A potential pitfall. Report of a unique and rare case","volume":"47","author":"Dubruc","year":"2019","journal-title":"Diagn. Cytopathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/873\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:44:26Z","timestamp":1777862666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["medicina62050873"],"URL":"https:\/\/doi.org\/10.3390\/medicina62050873","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]}}}